Our Physicians Teams in Poland, Germany and India approve health history questionnaires from Confirmatory Typing (CT) and workup (WU) requests, as well as donor post-donation follow-up.
Our physicians advise prospective donors on their eligibility to register as a potential lifesaver in support of our mission. In addition, they work closely with our Workup teams and consult in cases where potential donors have not been deemed medically fit to donate or further clarification is required. They also collaborate with all departments to clarify if a donor should be blocked for a period of time or excluded from the database due to health issues.
DKMS physicians in all entities are involved in investigating and reporting adverse events and reactions to health authorities as well as quality evaluation of hematopoietic progenitor cell (HPC) collections. They conduct medical training and workshops, compile various statistics and contribute to articles and press releases by our communications departments, as well as medical mailings, especially with regard to answering questions from our donors. They also ensure aligned and accurate medical and scientific communication, both internally and externally. They are responsible for the internal medical guidelines and eligibility criteria and constantly keep them in line with external regulations, new insights and learnings.
For ten years, our physicians in Germany have been in charge of a large study on long-term donor outcome. As part of this “Matched-Pair Study,” registered donors from our database have been matched to actual donors and receive identical follow-up questionnaires.
Results from our physicians’ own research and analyses are published and presented at medical congresses of national and international transplant societies, with our DKMS experts being active members of organizations such as WMDA. Currently, our physicians are heavily involved in addressing the challenges posed by the current coronavirus pandemic, and in the past, their international collaboration was key in the response to the Zika pandemic.